PATENT CLAIM ANALYSIS

Application Number: 16102155
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
In certain aspects, provided herein are RNA complexes (e.g., asymmetric RNA complexes, such as asiRNAs and lasiRNAs) that inhibit tyrosinase expression and are therefore useful for reducing melanin production and for treating pigmentation-related disorders associated with excessive melanin production, such as melasma and age spots.

Claim (Index 5):
The RNA complex of  claim 1 , wherein the antisense strand has a sequence selected from the antisense strand sequences listed in Table 1, Table 2, Table 4 and Table 5.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 96.0
- Lexical Diversity: 1.36842
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15220767', '16042833', '15352322', '15422122', '15422186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8238365714030406
- 35 USC 102 Novelty (BERT): 0.6431063116739513
- Combined Prediction Score: 0.8057635454301316
- Mean Citation Score: 478.835052
- Max Citation Score: 740.9342
- Similarity Product: 550.5391295373202

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test